Bristol-Myers Squibb 4Q10 4Q Revenues: $5.1 billion (+2%) 4Q Earnings: $483 million (-94%)* FY Revenues: $19.5 billion (+4%) FY Earnings: $3.1 billion (-71%)* Comments: U.S. sales rose 5% to $3.3 billion in 4Q10, while international sales dropped 5% to $1.8 billion (2% was due to currency exchange rates). 4Q10 Pharma sales were led by Plavix ($1.7 billion / +6%) and Abilify ($700 million / flat). The biggest gains were posted by Sprycel (+42% to $169 million), Baraclude (+25% to $...